<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110120</url>
  </required_header>
  <id_info>
    <org_study_id>2015/07JAN/008</org_study_id>
    <nct_id>NCT03110120</nct_id>
  </id_info>
  <brief_title>Interest of Serratus Plane Block in Postoperative Analgesia for Robot-assisted Surgery</brief_title>
  <official_title>Interest of Serratus Plane Block in Postoperative Analgesia for Patients Undergoing Robot-assisted Mitral Valve Repair, MIDCAB or Partial Lung Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the analgesia provided by the serratus plane block with
      local infiltration of the orifices of the trocars after thoracic robot-assisted surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In our hospital, the current practice to provide post operative analgesia for patients
      scheduled for robot-assisted mitral repair or oncological thoracic surgery is to dispense
      local anesthetics at the orifices of the trocars at the end of the surgery and to give a
      Patient Controlled Analgesia (PCA). Some of these patients are not comfortable and we observe
      a large percentage of chronic pain. Recently we tried to use the Serratus plane block
      realised before the beginning of the surgery, and it seemed that patients were more
      comfortable with a lower consumption of morphine. So we decided to perform a double blind,
      randomized study in this population of patients to compare the analgesia provided by the
      serratus plane block realized before the beginning of the surgery and the local infiltration
      of the wound at the end of the surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Compare the efficacy of the serratus plane block with local infiltration after thoracic robot-assisted surgery</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>The patient where randomized by the investigator after inform consent was signed The investigator prepared the syringes named &quot;serratus&quot; and &quot;local&quot; with levobupivacaine 0.25 or saline according to randomization The care provider injected the prepared syringes respectively in the serratus plane or locally without knowing their contents The outcome assessor evaluated the post operative pain and the 3 months followup without knowing the randomization</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>D0 pain intensity</measure>
    <time_frame>1 day</time_frame>
    <description>Self reported pain intensity the day of surgery. Each item is scored 0-100 (0 - no pain, 100 - pain as bad as can be)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>D1 pain intensity</measure>
    <time_frame>3 days</time_frame>
    <description>Self reported pain intensity the days after surgery. Each item is scored 0 - 100 (0 - no pain, 100 - pain as bad as can be)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>5 days</time_frame>
    <description>Consumption of morphine the day and 4 days after surgery as recorded on the PCA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>persistence of a chronic pain</measure>
    <time_frame>3 months</time_frame>
    <description>Phone call 3 month after surgery to evaluate the persistence of pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Analgesia</condition>
  <condition>Robotic Surgery</condition>
  <arm_group>
    <arm_group_label>serratus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Serratus plane block and local control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>serratus control and local anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% levobupivacaine injectable solution with 10 ml of physiological saline</intervention_name>
    <description>Serratus plane block realized with a mixture of 10 ml of 0.5% levobupivacaine injectable solution with 10 ml of physiological saline</description>
    <arm_group_label>serratus</arm_group_label>
    <other_name>serratus plane block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% levobupivacaine injectable solution with 10 ml of physiological saline</intervention_name>
    <description>local infiltration of the wound with a mixture of 10 ml of 0.5% levobupivacaine injectable solution with 10 ml of physiological saline</description>
    <arm_group_label>local</arm_group_label>
    <other_name>local anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% levobupivacaine injectable solution with physiological saline</intervention_name>
    <description>Serratus plane block realized with 20 ml of injectable solution of physiological saline</description>
    <arm_group_label>local</arm_group_label>
    <other_name>local serratus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% levobupivacaine injectable solution with physiological saline</intervention_name>
    <description>local infiltration of the wound with 20 ml of injectable solution of physiological saline</description>
    <arm_group_label>serratus</arm_group_label>
    <other_name>local control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mitral repair, coronary artery revascularization or thoracic surgery scheduled
             robot-assisted surgery

        Exclusion Criteria:

          -  non robot-assisted surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Watremez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Watremez Christine</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>October 7, 2017</last_update_submitted>
  <last_update_submitted_qc>October 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

